A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients

Abstract

The proposed 9-mRNA signature is a promising biomarker for predicting BCR-free survival in PCa. However, further controlled trials are needed to validate our results and explore a role in individualized management of PCa.